Specifically, expression and localization analysis revealed that TMEM88 was moderately elevated in breast cancer in situ and highly elevated in invasive breast ductal carcinoma compared with negative or low expression in normal breast tissue, which suggests that the expression of TMEM88 has potential as a marker for breast cancer classification. Here, TMEM88 is linked to invasive ductal breast carcinoma.